Ocuphire Pharma

IRD

NASDAQHealth Care

Income Statement

Total Revenue$10.99M

Gross Profit$10.99M

Operating Income$-62.07M

EBITDA$-57.52M

EBIT$-57.53M

Pre-tax Income$-106.93M

Net Income$-57.53M

Cash Equivalent$38.88M

Total Debt$0

Book Value$36.64M

Book Value Per Share1.35

Return on Equity (ROE)-225.02%

Return on Assets (ROA)-156.07%

Return on Invested Capital (ROI)-225.02%

Net Profit Margin-523.40%

Current Ratio3.24

Quick Ratio3.20

Long-Term Debt / Equity0.00